Akihito Usa

Usa-san will be superbly placed to guide our Byosphere customers, especially those in GxP and cloud-ready and Enterprise environments

CUPERTINO, Calif. (PRWEB)
October 08, 2021

Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today the addition of Akihito Usa as the Country Manager for Japan.

Usa has over 30 years of sales experience with enterprise software in the life science and health care industries, starting from MSI (now BIOVIA) in 1987. He has successfully launched new business and led local teams in Japan, including MDL (now BIOVIA) from 1995 – 2005, CambridgeSoft (now Perkin Elmer) from 2005 – 2014 and Arxspan (now Bruker) from 2014 – 2021.

“This continues the expansion of Protein Metrics in all geographies and recognises the need for local support for all of our customers,” said Eric Carlson, Ph.D., President and CEO of Protein Metrics. “With a background in enterprise software and data management, Usa-san will be superbly placed to guide our Byosphere customers, especially those in GxP and cloud-ready and Enterprise environments.”

Protein Metrics supports hundreds of organizations worldwide with its Byos® desktop software for protein characterization. The Company recently launched its Byosphere® Enterprise Platform to support collaboration across teams, projects, and geographies. Byosphere® strengthens an organization’s biotherapeutic knowledge, and is available as an on-premise or a private-cloud deployment. The Company also has an extensive and growing portfolio of patents and intellectual property covering current products and extends into potential new application areas. (https://www.proteinmetrics.com/about-us#patents )

About Protein Metrics

Protein analysis should never be limited by software. With a clear focus on protein characterization, Protein Metrics’ vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. Protein Metrics is headquartered in Cupertino, CA at the crossroads of computing and biotechnology in the San Francisco Bay Area. For more information, visit http://www.proteinmetrics.com.

Share article on social media or email:

Amprion R&D Assoc Director, Luis Concha, runs experiments

“Our technology detects the prion biomarkers in CSF samples years before patients show symptoms. Early diagnosis is crucial because it enables physicians to steer their patients to proper treatments.” – Claudio Soto, Ph.D. -Amprion Co-founder and Chief Scientific Officer

SAN FRANCISCO (PRWEB)
October 06, 2021

Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate and reliable detection of α-synuclein aggregates, a hallmark in various brain diseases.

The SYNTap Test aids in diagnosing synucleinopathies such as Parkinson’s, Lewy Body Dementia, and Multiple System Atrophy (MSA). In addition, the novel test helps distinguish underlying synucleinopathies in other neurodegenerative conditions, such as Alzheimer’s. Based on Amprion’s proprietary technology, Seed Aggregation Assay (SAA), the SYNTap Test identifies prion-like α-synuclein aggregates using a few drops of CSF (about one hundred microliters), confirming the presence of progressive brain disease. Test results are intended to accompany other clinical and diagnostic findings for patient case management.

“Before the SYNTap Test, there has been no specific, objective laboratory test for the diagnosis of neurodegenerative diseases such as PD, LBD, and MSA. Traditionally, patients are diagnosed based on clinical symptoms, which means their disease is relatively advanced,” said Amprion Co-founder and Chief Scientific Officer Claudio Soto, Ph.D. “Our technology detects the prion biomarkers in CSF samples years before patients show symptoms. Such early diagnosis is crucial because it enables physicians to steer their patients to proper treatments.” In addition, patients can make lifestyle changes early when their brain is healthier and more responsive to intervention. Until now, early diagnosis was not an option.

“Brain diseases affect individuals differently. For instance, ten patients can have ten different biomarker profiles,” said Dr. Russell Lebovitz, MD, Amprion CEO and co-founder. “Symptoms often overlap, leading to misdiagnosis 40 to 50% of the time. In addition, diagnosis significantly impacts drug treatment as wrongly prescribed medication can harm patients instead of helping them. The SYNTap Test provides physicians a molecular tool to greatly improve diagnostic accuracy. This is vital because personalized medicine is the key in treating neurodegenerative disorders.”

Recently awarded a US FDA Breakthrough Device Designation, Amprion’s prion detection research has been supported by the National Institutes of Health under award numbers 1R42AG058333 and 1U44NS111672, Alzheimer’s Drug Discovery Foundation (ADDF), The University of Texas McGovern Medical School, and The Michael J. Fox Foundation.

Performed exclusively at Amprion’s CLIA-registered laboratory in San Diego, California, the SYNTap Test is available throughout the US except for Maryland, New York, Pennsylvania, and Rhode Island. Market rollout in these states is expected within the next six months.

Currently, 5.8 million people are diagnosed with Alzheimer’s in the US annually, 1.4 million with LBD, and 1.5 million with Parkinson’s, adding to the millions already suffering from these diseases without a cure. And these numbers are expected to triple by 2050.

“Our ultimate goal is to find a cure for brain diseases. Now that we can accurately detect the biomarker early, we’ll make great strides to accelerate research and innovation. Amprion is on a mission to advance personalized medicine through biomarker testing,” said Dr. Lebovitz.

To order the SYNTap Biomarker Test, doctors can register online. For more information, please visit Amprion’s Physicians Center.

ABOUT AMPRION

A leader in prion detection research, Amprion innovates biomarker testing, enabling doctors to accurately diagnose Parkinson’s, Lewy Body Dementia, and other synucleinopathy. The test identifies misfolded protein aggregates driving various neurodegenerative conditions at all stages. The company anticipates rolling out other biomarker tests, including abeta and tau.

Share article on social media or email:

“I’ve long been impressed with Specifics’ technology and rapid AST solution. There is a clear need for a rapid AST to compliment rapid ID and based on the Reveal system’s throughput, ease of use and price, it’s poised for wide-spread adoption.” said Mr. Mendel.

MOUNTAIN VIEW, Calif. (PRWEB)
October 05, 2021

Specific Diagnostics today announced the appointment of Scott Mendel to its Board of Advisors. Mr. Mendel is an industry veteran with over 30 years in public and private corporate leadership. Mr. Mendel had served since 2020 as the Chief Executive Officer of public company GenMark, overseeing its rapid growth to $200M in annual sales, and the process that led to its purchase by Roche Diagnostics for $1.8B in Q2 of this year. Mr. Mendel had previously served as GenMark’s COO and CFO, and has extensive experience both in finance and manufacturing scale-up, as well as general commercial operations and strategy. Prior to joining GenMark, Mr. Mendel held CFO positions at The Active Network and GE Healthcare.

“Scott is a highly regarded leader in this industry and will bring great value to our company,” said Dr. Paul A. Rhodes, Specific’s CEO. “He is joining Specific’s distinguished Advisory Board at the perfect time as we move into commercialization of the Reveal product in Europe and soon the US. His 8 year experience helping to navigate GenMark to a superb outcome in a competitive market speaks for itself. I look forward to working with him closely across a wide range of activities.”

“I am glad to welcome my former GenMark colleague and CEO to Specific at this critical time in our commercial launch,” noted Johnny Ek, Specific CFO and former GenMark CFO. “Scott’s expertise in rapid diagnostics along with his operational business acumen are perfectly suited to help Specific capitalize on the opportunity we have to bring a winning rapid AST system to this critical unmet need in the market.”

“I’m honored and excited to a be part of the Specific Diagnostics’ Advisory Board,” said Mr. Mendel. “I’ve long been impressed with Specifics’ technology and rapid AST solution. There is a clear need for a rapid AST to compliment rapid ID and based on the Reveal system’s throughput, ease of use and price, it’s poised for wide-spread adoption.”

Mr. Mendel holds a B.S. in finance from Indiana University Bloomington and an MBA from the Kellogg School of Management, Northwestern University.

Share article on social media or email:

Mariano Rivera and Pinktie Charities in partnership with Keller Williams Core announce “MVP of the Year” winner, raising over $250,000 towards STEM learning centers in New Rochelle, NY

Mariano, as the natural leader he is, inspired us to achieve at the highest limits, as a team, so the local kids can be their best too.

NEW YORK (PRWEB)
October 04, 2021

The “MVP of the Year,” a fundraising program led by PinkTie Charities in partnership with Keller Williams Core to raise a total of $250,000 to help construct two STEM classrooms at the Mariano Rivera Learning Center in New Rochelle, New York, announces the winning team of their year-long initiative; Allan Zapadinsky of Keller Williams NYC and Team Ground Breaking Ballers.

“At a time when it feels like ‘what’s in it for me?’ is a first instinct, I found myself in so many moments throughout this fundraising effort thinking ‘what else can I do for others?’” says Zapadinsky.

“Mariano, as the natural leader he is, inspired us to achieve at the highest limits, as a team, so the local kids can be their best too.”

The STEM classrooms will create an environment that expands students’ knowledge in technology, engineering, mathematics, coding and product developments. All learning center students will have the opportunity to participate in activities related to coding, UX/UI design, engineering and robotics on site or virtually. Unanimous Baseball Hall-of-Famer and five-time World Series champion, Mariano Rivera, is the ambassador of MVP of the year and leads the Mariano Rivera Foundation.

“Together, as we launch the MVP Program, we will raise much needed funds to help build our Learning Center in New York to support and stabilize the future of our students living in low income communities,” explains Mariano Rivera.

“We are grateful for organizations like Keller Williams and PinkTie and appreciate all of the MVP of the Year fundraisers and teams who have committed their time and energy to this program for the sake of the underserved minority youth. The MVP of the Year program will help Learning Center students receive access to two STEM learning initiatives which will prepare them for a successful and advantageous future,” says Rivera.

The “MVP of the Year” program consists of 10 teams all competing to see who raises the most money to help construct the two STEM Learning classrooms.

Each team ran their own fundraising events, virtual giveaways and auctions to raise a guaranteed minimum of $25,000 each. Due to last year’s COVID-19 restrictions, the 2020 winning team, “Ground Breaking Ballers,” was announced on September 23, 2021 at the Keller Williams NYC office at 99 Park Ave, New York, NY and awarded the title of “MVP of the Year,” raising nearly $40,000. All proceeds raised from the MVP of the Year fundraising program will benefit and help construct two STEM classrooms at the Mariano Rivera Learning Center by 2022.

“Throughout the duration of this program, we can connect with one another again (from a distance) and continue to cultivate a company culture that focuses on giving back. Now more than ever, corporations and philanthropies need to engage and uplift one another to support communities in need,” says Mike Cave, CEO of 1st Equity Title Insurance and Co-Founder of PinkTie Charities.

To support the various fundraisers to create two STEM Learning Classrooms at the Mariano Rivera Learning Center, view this year’s event highlights, and learn more about the MVP of the Year fundraising competition, please visit: mvpoftheyear.org

About PinkTie:

PinkTie is a community-led charity that tackles tough social and economic problems with urgency and a long-term approach to create access to opportunity for people in underserved communities in New York State. In 2020, PinkTie founded MVP of the Year and partnered with Keller Williams-New York and the Mariano Rivera Foundation to build two STEM Learning Classrooms at the Mariano Rivera Learning Center in New Rochelle, New York. The curriculum will teach science, technology, engineering and mathematics and provide equitable learning environments for students at risk and from low-income communities.

About Keller Williams Core:

Keller Williams Core builds careers worth having, businesses worth owning, lives worth living, experiences worth giving, and legacies worth leaving. Keller Williams Core is a full-service, luxury real estate brokerage representing clients in a broad spectrum of classes, including residential sales and leasing, new development, commercial, and retail.

Share article on social media or email:

“Politicians Can’t Stop Climate Change” – Friends of Science Society’s 18th Annual Event

Greta Thunberg excoriated world politicians for climate blah blah blah and not responding to what she claims is a climate emergency, but Friends of Science Society’s upcoming event confirms that “Politicians Can’t Stop Climate Change” and Greta’s blah blah blah is misinformed.

CALGARY, AB (PRWEB)
September 30, 2021

As reported in The Guardian of Sept. 28, 2021, Greta Thunberg excoriated world politicians for climate blah blah blah and not responding to what she claims is a climate emergency, but Friends of Science Society’s upcoming event confirms that “Politicians Can’t Stop Climate Change” and Greta’s blah blah blah is misinformed.

Dr. Guus Berkhout, president of CLINTEL, the climate intelligence organization of over 900 signatory scientists and scholars who say there is no climate emergency, will present “Climate Science: Let the Data Speak” on Oct. 2, 2021, at 10 a.m. MDT as part one of Friends of Science Society’s 18th Annual Free Event online. Live stream link.

Marc Morano, author, and climate realist activist will counter many of Greta’s claims to phase out fossil fuels ‘immediately’ in his presentation “Green New Deal: The Great Regret”, part two of Friends of Science online event on Oct. 6, 2021, at 7 p.m. MDT. Live stream link. Marc offers the public an entertaining exposé of climate hypocrisy and the muddled messages from climate catastrophe reporters. But his presentation further warns the public of the dangers of COVID lockdown becoming the method of choice for climate fanatics intent on reducing emissions. Live Q&A will follow both presentations.

As Dr. Berkhout and colleagues show in the CLINTEL World Climate Declaration, ‘the science’ reveals there is no climate emergency, therefore there is no need to turn world energy systems upside down or strive for NetZero2050 targets.

People may wonder why the climate emergency is over, when governments around the world have embraced this theme for a few years, says Friends of Science.

The reason is found in peer-reviewed research by Roger Pielke, Jr., and Justin Ritchie, who found that ‘the science’ of climate emergency is all based on an implausible scenario known as RCP 8.5* and outdated science premises. (*Representative Concentration Pathways – 4 scenarios developed for climate research, not meant to be used for climate policy making.)

As Pielke, Jr. explains in a post entitled “The Unstoppable Momentum of Outdated Science”, this type of repetitive research error has occurred in medical research on breast cancer as well, where thousands of scientific papers were published, all based erroneously on a skin cancer cell-line.

It should be a great relief to people around the world that without reference to the RCP 8.5 scenario, there is no climate emergency and we do have time for a more thoughtful implementation of new energy technologies, says Friends of Science.

Furthermore, taxpayers will be relieved that the upcoming COP26 in Glasgow seems likely to fall apart, largely because of the attempted extortion of trillions of dollars from Western OECD nations by developing nations. Originally promised a $100/bn a year Green Climate Fund to be drawn from OECD nations as a bribe to get on board the Paris Agreement, the financial appetites of emerging nations have grown exponentially. As Canadian energy economist Robert Lyman explains in “COP26 Climate Conference in Glasgow – Show Me the Money!” Americans may be held hostage for a proposed $80 billion a year for green climate funding – a far cry from the April 2021 commitment by U.S. President Biden to increase climate aid to $5.7 billion annually by 2024!

As Friends of Science Society has always said, open, civil debate and full cost benefit analysis of climate and energy policies are essential for good public policy. Recent peer reviewed science shows that climate models overstate atmospheric warming, and the UN IPCC’s method of attributing warming to greenhouse gases is flawed, thus carbon dioxide’s warming effect on climate is no longer seen to present any imminent existential threat, consequently we do have time.

About

Friends of Science Society is an independent group of earth, atmospheric and solar scientists, engineers, and citizens that is celebrating its 19th year of offering climate science insights. After a thorough review of a broad spectrum of literature on climate change, Friends of Science Society has concluded that the sun is the main driver of climate change, not carbon dioxide (CO2).

Friends of Science Society

P.O. Box 23167, Mission P.O.

Calgary, Alberta

Canada T2S 3B1

Toll-free Telephone: 1-888-789-9597

Web: friendsofscience.org

E-mail: contact(at)friendsofscience(dot)org

Web: climatechange101.ca

Share article on social media or email:

Society of Biomolecular Imaging and Informatics to Host “High Content 2021,” October 4-6, 2021.

DURHAM, N.C. (PRWEB)
September 22, 2021

SBI2 to hold “High Content 2021” on October 4th – 6th, 2021, on the Labroots platform.

Here is what to expect at SBI2’s “High Content 2021” conference:

Monday

Tuesday

• Keynote presentation
• Digital networking opportunities
• Poster session with live chat and video
• Roundtable discussions
• Presentations

Wednesday

• Keynote Presentation
• Poster session with live chat and video
• Roundtable discussions
• Presentations
• Award Ceremony and Annual General Meeting

To register for the event, and view the agenda and speakers, click here.

About SBI2:

The Society of Biomolecular Imaging and Informatics (SBI2) is an international community of leaders, scientists, and students promoting technological advancement, discovery, and education to quantitatively interrogate biological models to provide high context information at the cellular level.

About Labroots:

Labroots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Not registered yet as a Labroots user? Click here to sign up for free.

Share article on social media or email: